Sanolium AB interim report April - June 2023
Revenue in the second quarter amounted to 273.0 MSEK, representing a growth of 24.4%CEO´s comment Cambio continues to take steps on the journey to implement our strategy and to digitize health and social care in our prioritized markets. The second quarter has been characterized by continued build-up of our business within key customer groups. For Sussa Samverkan, one of our major customer groups consisting of 9 Swedish regions, we have passed the Acceptance Test 2 in April, meaning that our solution has had the final acceptance from our customers. This means that we can now continue